Search
Browse
Statistics
Feeds

Assessing the contribution of rare variants to congenital heart disease through a large-scale case-control exome study

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
53MB
[thumbnail of Supplementary Information] Other (Supplementary Information)
30MB

Item Type:Article
Title:Assessing the contribution of rare variants to congenital heart disease through a large-scale case-control exome study
Creators: Audain, Enrique, Wilsdon, Anna, Dombrowsky, Gregor, Sifrim, Alejandro, Breckpot, Jeroen, Perez-Riverol, Yasset, Loughna, Siobhan, Daly, Allan, Antoniou, Pavlos, Hofmann, Philipp, Perez-Riverol, Amilcar, Kahlert, Anne-Karin, Bauer, Ulrike, Pickardt, Thomas, Klaassen, Sabine ORCID logoORCID: https://orcid.org/0000-0001-5925-9912, Berger, Felix, Daehnert, Ingo, Dittrich, Sven, Stiller, Brigitte, Abdul-Khaliq, Hashim, Bu'lock, Frances, Uebing, Anselm, Kramer, Hans-Heiner, Iyer, Vivek, Larsen, Lars Allan, Brook, J. David and Hitz, Marc-Phillip
Abstract:Several studies have demonstrated the value of large-scale human exome and genome data analysis to maximise gene discovery in rare diseases. Using this approach, we have analysed the exomes of 4747 cases and 52,881 controls to identify genes which confer a substantial risk of congenital heart disease (CHD). We identified both rare loss-of-function and missense coding variants in 14 genes, which reached genome-wide significance at FDR 5%. Ten genes have been associated with CHD, whereas four genes (PBX1, KAT6B, SHOX2, HCAR1) have not been reported as genome-wide significant so far. We highlight distinct genetic contributions to syndromic and non-syndromic CHD by independently analysing probands from these two groups. In addition, by integrative analysis of exome data with single-cell transcriptomics data from human embryonic hearts, we identified cardiac-specific cells, such as neural crest cells and endothelial cells, as well as putative biological processes underlying the pathogenesis of CHD. In summary, our findings strengthen the association of known CHD genes and have identified additional novel disease genes contributing to the aetiology of CHD.
Source:NPJ Genomic Medicine
ISSN:2056-7944
Publisher:Nature Portfolio / Center of Excellence in Genomic Medicine Research
Volume:11
Number:1
Page Range:30
Date:2 June 2026
Official Publication:https://doi.org/10.1038/s41525-026-00582-z
PubMed:View item in PubMed
Related to:

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library